Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationFrancis J. Giles, Elihu H. Estey, H. Kantarjian et al.|Cancer|2001Cited by 280
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular CarcinomaManal M. Hassan, Donghui Li, Alexandria T. Phan et al.|Gastroenterology|2015Cited by 107